Risk Summary There is no information regarding the presence of lixisenatide and insulin glargine in human milk, the effects on the breastfed infant, or the effects on milk production
That process is underway, it is accelerating, and its implications will shape the peptide manufacturing landscape for the next decade
Reddy s Laboratories Ltd., Lupin Limited, Intas Pharmaceuticals Ltd., Alvotech, Bio-Thera Solutions Ltd., Organon & Co., Fresenius Kabi AG, Coherus BioSciences Inc., Dong-A ST Co., Ltd., Gan & Lee Pharmaceuticals, Hikma Pharmaceuticals PLC, Shanghai Henlius Biotech Inc., and Zhejiang Huahai Pharmaceutical Co., Ltd
Individual results vary, and medical supervision is required
We ensure that tirzepatide is used safely and effectively, monitoring for any potential side effects and offering guidance throughout the treatment process